Nov 18, 2020 / 03:40PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome, everybody, to Day 3 of the 2020 Stifel Healthcare conference. This is the Life Sciences and Diagnostic track. And we're happy to have Repligen as the next company with us today.
Today, right now, I have Jon Snodgres, who's the CFO; and then Tony Hunt, the CEO, will be joining us in a little bit, once we wrap some things up. So Jon, welcome. Thanks for spending some time.
Jon K. Snodgres - Repligen Corporation - CFO & Secretary
It's our pleasure to be here. Thank you, Dan.
Questions and Answers:
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior AnalystYes, for sure. I think maybe just a good starting point would be to talk about the year. I mean 2020 has been an active year for everybody. But certainly for you guys, just given the customers that you serve and what those customers have been doing this year, can you just
Trustpilot
